Improving access to HIV prevention for young women in Kenya through pharmacies
Enhancing PrEP outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform
This study is looking to make it easier for young women in Kenya to get HIV prevention medication called PrEP by offering it at local pharmacies, where they already go for other health needs, with the help of trained nurses to guide them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10902090 on NIH RePORTER |
What this research studies
This research aims to enhance the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention among adolescent girls and young women in Kenya by utilizing retail pharmacies. The approach involves training nurse-navigators to facilitate access to PrEP in pharmacies, where many young women already seek contraception. By integrating PrEP delivery into familiar settings, the study seeks to increase the uptake and adherence to PrEP among this high-risk population. The research will be conducted in Kisumu, Kenya, a region with a high prevalence of HIV, and will evaluate the effectiveness of this pharmacy-based model.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women in Kenya who are at risk for HIV and seeking contraception.
Not a fit: Patients who are not at risk for HIV or those who do not seek contraception may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV incidence among adolescent girls and young women in Kenya by improving access to effective prevention methods.
How similar studies have performed: Previous research has shown success in integrating PrEP delivery into family planning services, indicating potential for this novel pharmacy-based approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Pintye, Jillian — University of Washington
- Study coordinator: Pintye, Jillian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.